The GSR is an expansion of the highly successful Fred Hutchinson Cancer Research Center (FHCRC) DNA (deoxyribonucleic acid) Array Laboratory launched in 1998, which was one of the first microarray core laboratories in the country. Initially, the resource was instrumental in assisting researchers in the development of a number of novel microarray applications, including assays examining protein-DNA interactions, DNA methylation profiling, and DNA replication timing patterns. The resource then transitioned from primarily making custom spotted arrays to using several commercial array-based platforms. The DNA Array Lab was later incorporated into a new entity - the Consortium Genomics Shared Resource - along with a newly developed second laboratory, the Genetic Analysis Lab, which was developed to provide capillary-based sequencing services (and years later also provide NextGen sequencing services). This expansion also required an expansion of support infrastructure and instrumentation for the main service areas. A major component of this infrastructure is HutchBASE, an in-house developed Laboratory Information and Management System (LIMS) system that supports online ordering of services, sample tracking, data management and analysis, and billing. The resource provides the highest quality services and expertise to aid the genomics-based needs of Cancer Consortium members through its two laboratories. The Genetic Analysis Laboratory provides: ? Capillary-based and NextGen sequencing technologies; ? Genotyping; and ? Quantitative (real-time) polymerase chain reaction (qPCR) services. The deoxyribonucleic acid (DNA) Array Laboratory provides Consortium members with end-to-end solutions for array-based experimentation, including: ? Consultation on technology selection; ? Assistance with experimental design; ? Assessment of RNA and DNA quality; ? Troubleshooting support; and ? Assistance with reviewing data quality and implementation of data analysis strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-43
Application #
9406706
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
43
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Miller, Chris P; Tsuchida, Connor; Zheng, Ying et al. (2018) A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis. Neoplasia 20:610-620
Baker, K Scott; Syrjala, Karen L (2018) Long-term complications in adolescent and young adult leukemia survivors. Hematology Am Soc Hematol Educ Program 2018:146-153
Gavvovidis, Ioannis; Leisegang, Matthias; Willimsky, Gerald et al. (2018) Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Clin Cancer Res 24:3644-3655
Paulson, K G; Voillet, V; McAfee, M S et al. (2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A et al. (2018) Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biol Blood Marrow Transplant 24:2211-2215
Witzky, Anne; Hummels, Katherine R; Tollerson 2nd, Rodney et al. (2018) EF-P Posttranslational Modification Has Variable Impact on Polyproline Translation in Bacillus subtilis. MBio 9:
Rosenthal, Elisabeth A; Shirts, Brian H; Amendola, Laura M et al. (2018) Rare loss of function variants in candidate genes and risk of colorectal cancer. Hum Genet 137:795-806
Verboon, Jeffrey M; Decker, Jacob R; Nakamura, Mitsutoshi et al. (2018) Correction: Wash exhibits context-dependent phenotypes and, along with the WASH regulatory complex, regulates Drosophila oogenesis (doi:10.1242/211573). J Cell Sci 131:

Showing the most recent 10 out of 1267 publications